BLAUVELT, A. .; IVERSEN, L.; MCBRIDE, S. .; GOODERHAM, M.; STAUBACH, P.; YAMAUCHI, P.; STAELENS, F.; VANOORDEN, V.; WHITE, K. .; GISONDI, P. Bimekizumab versus secukinumab efficacy across subgroups of patients with moderate to severe plaque psoriasis: Results from the multicenter, randomized, double-blinded phase 3b BE RADIANT trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 6, p. s53, 2021. DOI: 10.25251/skin.5.supp.53. DisponĂ­vel em: Acesso em: 8 aug. 2022.